These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3039879)
1. Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. Gangadharam PR; Perumal VK; Jairam BT; Rao PN; Nguyen AK; Farhi DC; Iseman MD Am Rev Respir Dis; 1987 Aug; 136(2):329-33. PubMed ID: 3039879 [TBL] [Abstract][Full Text] [Related]
2. Activity of rifabutin alone and in combination with clofazimine, kanamycin and ethambutol against Mycobacterium intracellulare infections in mice. Saito H; Sato K Tubercle; 1989 Sep; 70(3):201-5. PubMed ID: 2559522 [TBL] [Abstract][Full Text] [Related]
3. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Gangadharam PR; Perumal VK; Podapati NR; Kesavalu L; Iseman MD Antimicrob Agents Chemother; 1988 Sep; 32(9):1400-3. PubMed ID: 2848444 [TBL] [Abstract][Full Text] [Related]
4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931 [TBL] [Abstract][Full Text] [Related]
5. Treatment of nontuberculous mycobacterial infections in pediatric patients. Levin RH; Bolinger AM Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317 [TBL] [Abstract][Full Text] [Related]
6. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. Hoy J; Mijch A; Sandland M; Grayson L; Lucas R; Dwyer B J Infect Dis; 1990 Apr; 161(4):801-5. PubMed ID: 2156947 [TBL] [Abstract][Full Text] [Related]
7. In vivo activities of newer rifamycin analogs against Mycobacterium avium infection. Klemens SP; Cynamon MH Antimicrob Agents Chemother; 1991 Oct; 35(10):2026-30. PubMed ID: 1662021 [TBL] [Abstract][Full Text] [Related]
8. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes. Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J Tubercle; 1991 Sep; 72(3):168-75. PubMed ID: 1663282 [TBL] [Abstract][Full Text] [Related]
9. TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice. Cynamon MH; Klemens SP; Swenson CE J Antimicrob Chemother; 1992 Jun; 29(6):693-9. PubMed ID: 1387133 [TBL] [Abstract][Full Text] [Related]
11. Rifabutin (ansamycin LM427) for the treatment of pulmonary Mycobacterium avium complex. O'Brien RJ; Geiter LJ; Lyle MA Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):821-6. PubMed ID: 2158257 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo chemotherapeutic activity of rifabutin (LM 427) on Mycobacterium avium-intracellulare complex. Sakurai N; Kuze F Bull Chest Dis Res Inst Kyoto Univ; 1987 Mar; 20(1-2):50-60. PubMed ID: 2836007 [No Abstract] [Full Text] [Related]
13. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols]. Tomioka H; Saito H Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724 [TBL] [Abstract][Full Text] [Related]
14. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Bermudez LE; Kolonoski P; Young LS; Inderlied CB Antimicrob Agents Chemother; 1994 Aug; 38(8):1844-8. PubMed ID: 7986018 [TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity in vivo of LM427 (rifabutin). Orme IM Am Rev Respir Dis; 1988 Nov; 138(5):1254-7. PubMed ID: 2849349 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice. Saito H; Tomioka H; Sato K; Kawahara S; Hidaka T; Dekio S Tuber Lung Dis; 1995 Feb; 76(1):51-8. PubMed ID: 7718848 [TBL] [Abstract][Full Text] [Related]
17. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi]. Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379 [TBL] [Abstract][Full Text] [Related]
18. MAC management. PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967 [TBL] [Abstract][Full Text] [Related]
19. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi]. Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093 [TBL] [Abstract][Full Text] [Related]
20. Effect of rifabutin on the phagocytosis and intracellular growth of Mycobacterium intracellulare in mouse resident and activated peritoneal and alveolar macrophages. Perumal VK; Gangadharam PR; Iseman MD Am Rev Respir Dis; 1987 Aug; 136(2):334-7. PubMed ID: 3039880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]